ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DIETER MARTIN MD

Internal Medicine

23,891

$1.73M

583
497 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

HAROLD PEAN MD

Internal Medicine

23,775

$2.37M

667
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$100
Average prescription price

Avg: $67

FRANCIS GUMBEL MD PA

Internal Medicine

23,447

$1.26M

844
717 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

RAMON COLEN M.D.

Internal Medicine

23,431

$1.02M

917
751 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

DAVID KUBAN D.O.

Internal Medicine

23,326

$1.35M

740
673 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

KENT ROGERS MD

Internal Medicine

23,317

$1.14M

735
631 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

RONALDO FACTORIZA M.D.

Internal Medicine

23,247

$1.62M

828
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

JOSE BENAMU M.D. P.A.

Internal Medicine

23,110

$872K

961
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$38
Average prescription price

Avg: $67

FLOYD PIRTLE M.D.

Internal Medicine

23,033

$980K

976
853 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

SATHIYARAJ GEORGE MD

Internal Medicine

22,966

$1.78M

1121
917 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$78
Average prescription price

Avg: $67

ROY CAIVANO D.O

Internal Medicine

22,731

$1.57M

549
351 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

LEO EDWARDS M.D.

Internal Medicine

22,632

$1.16M

991
472 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

JAYARAM NAIDU MD

Internal Medicine

22,620

$1.32M

852
690 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

JEREMY SMYRL DO

Internal Medicine

22,548

$1.55M

488
405 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

RAUL RIVERA MD

Internal Medicine

22,404

$1.25M

759
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

QUANG LE DO

Internal Medicine

22,387

$1.22M

678
511 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

SAMUEL OLOYO M.D.

Internal Medicine

22,383

$1.5M

519
338 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

48%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

DAVID BOUCHER MD

Internal Medicine

22,319

$1.21M

695
588 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

EDWARD MCCOIG MD

Internal Medicine

22,284

$1.06M

780
658 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

GARY EVANS MD

Internal Medicine

22,254

$1.24M

713
541 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

SANJEEV BHATIA M.D.

Internal Medicine

22,214

$1.41M

769
509 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

NORMAN DAVENPORT MD

Internal Medicine

22,084

$1.34M

851
795 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MARVIN MOSZKOWICZ M.D.

Internal Medicine

22,050

$1.42M

625
564 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

MARK BING M.D

Internal Medicine

21,796

$1.32M

711
620 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

VIPUL PATEL MD

Internal Medicine

21,787

$1.07M

699
459 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank